Correction to: The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations

Correction to: J Neurol DOI 10.1007/s00415-017-8594-9

Unfortunately, the online published article has errors in Table 2. The Peginterferon is listed as IM, when it should be SC.

The correct table (Table 2) is given in the following page.

Table 2 Mechanism of action and effects on the immune system of DMTs for RMS